Assignee
SHANGHAI LONGYAO BIOTECHNOLOGY INC LTD
CN·3 granted patents·3 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
6 records- 0154US2023134345A1Chimeric antigen receptor comprising third signal receptor and use thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2022·Application pending·0 cites
- 0253US12359169B2Universal CAR-T cell and preparation method and use thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2022·Granted Jul 15, 2025·0 cites·5 claims
- 0352US2023277666A1Chimeric antigen receptor comprising co-stimulatory receptor and application thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2023·Application pending·0 cites
- 0447US11524034B2Chimeric antigen receptor comprising third signal receptor and use thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2020·Granted Dec 13, 2022·0 cites·6 claims
- 0545US11590168B2Chimeric antigen receptor comprising co-stimulatory receptor and application thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2020·Granted Feb 28, 2023·0 cites·7 claims
- 0645US2021108175A1Universal car-t cell and preparation method and use thereofSHANGHAI LONGYAO BIOTECHNOLOGY INC LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI LONGYAO BIOTECHNOLOGY INC LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →